Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hello Badman,& ALL SHAREHOLDERS
FINRA Haulted trading on 200 OTC stock in ERROR. FINRA is beginning to open all of them a little at a time. The Bid & Ask price on SCRH on will begin to show up once this is resolved.No bad news on the Company that I can fine.
Thanks Blackcat7717
DIANNEDAWN THE CORRECT QUESTION IS WHO IS BUYING THE SHARES. REMEMBER THE MARKET MAKERS CAN SHORT THE STOCK IF THEY THINK THE STOCK IS GOING LOWER.iT HAS MOVED FROM $.0025 TO $.012. A MOVE OF 500% FROM THE BOTTOM. AFTER WE GO THREW $.01 THEY WILL BE JUMPING ALL OVER EACH OTHER TO REPLACE THE SHARES THEY SOLD. REMEMBER WHEN THIS STOCK WAS AT $.10 THEIR WERE 25 MARKET MAKER TRADING TAUG NOW ONLY 7.
TIC TOC TIC TOC WHAT TO DO $$$$$$$$$$$$$$$$$
BLACKCAT
clearmont88, Thanks you for your kind words about Seth and the company. Some day I hope to met you. If you need to check me out
talk to Seth.
Thanks
Blackcat
Hello Clearmont88,
Nice having you on board. I have been a long term shareholder I have been criticized 1000 times for buying TAUG @ .009. What I never told this board is I bought 3 times as many shares @ .0035. My average is .005. Seth is one of the most honest guy I have ever met. Some of the failures from the past were not his fault. Being a CEO is a risky proposition. Some on this board would like to think it is easy to be a CEO of a public company. I have posted the question to all on this board many times if they ever have experience with having a top position in any PUBLIC COMPANY.
All I would hear is total silence.
Seth will complete making TAUG a great company. Those posting negative post will never make any money with TAUG. That is sad.
TIC TOC TIC TIC WHAT TO DO !!!!!!!!!!!!!
BLACKCAT
It looks like we are on track to a LARGE settlement. The judge will not want this to go to trial and will likely force arbitration.
TIC TOC TIC TOC WHAT TO DO
BLACKCAT
I thought this lawsuit was nothing and was going to be thrown out.
TIC TOC TIC TOC WHAT TO DO
BLACKCAT
IMO, I think TAUG will be fully reporting before the month is out.
A brand new ball game at that point.
TIC TOC TIC TOC WHAT TO DO.
BLACKCAT
I also found out the company raised more than $400,000 from private investors since the time of being DELISTED.
TIC TOC TIC TOC WHAT TO DO?
BLACKCAT
I did some digging and Johnny C. is not a director of TAUG.
TIC TOC TIC TOC WHAT TO DO?
BLACKCAT
IMO I think $4 - 6 million is in site on this case. Any other thoughts?
TIC TOC TIC TOC WHAT TO DO ?
BLACKCAT
Many months ago it was rumored that a settlement for $200,000. would be a good settlement. Based on the new info with this case what do you think on this message board?
TIC TOC TIC TOC WHAT TO DO?
BLACKCAT
Now that the Judge ruled that the case will stay in Fla. Does anyone know when the Deposition will take place.
TIC TOC TIC TOC WHAT TO DO?
BLACKCAT
To All Investors. Did anyone check out the lawsuit website?
http://cowangunteskicpamalpractice.com/
http://cowangunteskicpamalpractice.com/
TIC TOC TIC TOC WHAT TO DO.
BLACKCAT7717
Good answer Deaf, however if someone is raising money for the company to fight the legal matters I am all for it. Over time it will be a successful . This will be a good thing. I would prefer to have more shares OutStanding rather than have TAUG go belly up. RESTRICTED SHARES cannot be sold under RULE 144 until 6 months up to 1 year of ownership. Anyone holding RESTRICTED SHARES are betting on the companies success over the long term. If the company is awarded several million dollars in the lawsuit TAUG can buy back many shares in the open market at this very low price. This will reduce the total OS. Consultants at times might have had an option to to get paid by the hour or take equity. The shares they own amount to nothing until the company becomes a winner.
How many of you on the message board would work for any company and for no compensation at all?
TIC TOC TIC TO WHAT TO DO
BLACKCAT
Hi Badman,
I have been buying more SCRH as it has been coming down. I am not happy with the latest filings, however it is fully reporting and will see better days in the future.
In reference to TAUG that I told you about. I am confident that a rise in the stock will take place soon. The message board has Naked Short sellers have tried to destroy TAUG and they will not win this one. Within several weeks TAUG will be fully reporting and make a decision on one of three companies to merge with. Try to stay up on any Press Releases and bypass the message board.
Blackcat
Your post would be great if your facts were correct.They are not.
The trial location does not matter. The courts will decide where this case will be heard.
The Jury verdict does matter. $$$$$$$$$$$$$$$$$$$$$
Blackcat
Deaf, Tauriga has no incentive to drag out a case when it has limited resources. Tauriga counsel is Florida based. So why would Tauriga try to Change venues to NJ???
This was a completely false piece of info you posted on many levels Blackcat
deaf, you need to get the facts correct.
Tauriga Sciences Inc. Responds in Federal Court to the Multiple Motions Filed by Cowan Gunteski
NEW YORK, NY–(Marketwired – Jul 7, 2016) – Tauriga Sciences, Inc. (OTC PINK: TAUG) (“Tauriga” or the “Company”), a life sciences technology Company, today announced that it has filed its Response with Untied States District Court Southern District Florida, Case No. 0:15-cv-62334, to answer the multiple motions filed by Cowan Gunteski & Co. P.A. (“Cowan Gunteski”) on June 13, 2016. At this point, Cowan Gunteski has ten days to Respond to Tauriga’s submission and at a date subsequent to that, the federal judge will make a ruling. Irrespective of this ruling, the Company will continue to prosecute this lawsuit against Cowan Gunteski and believes strongly in the evidentiary record and the merits of its legal arguments. The Company is currently seeking in excess of $3,000,000 USD in monetary damages and expects that number to continually increase up till the date of trial.
On June 29, 2016 the Company filed its Quarterly Report on Form 10-Q (“Quarterly Report”) for the period ended June 30, 2015. The Company continues to work diligently towards its corporate goal of regaining its status as a fully reporting U.S. public Company. The Company became a delinquent filer and was delisted from the OTCQB Exchange on July 31, 2015 due to the malpractice committed by Cowan Gunteski during Fiscal Year 2014 as well as Cowan’s subsequent conduct.
Lastly the Company wishes to reaffirm to shareholders its unwavering commitment to both restore and create lasting shareholder value. The Company’s management and its Board of Directors are united in their commitment to build long term value for the shareholders. The Company continues to evaluate potentially intriguing acquisition opportunities and will notify shareholders, via a press release, should it enter into an agreement.
bad, SETH SHAW has been kick to to curb so many times by dishonest individual, I think he has learned to keep quiet about any meetings he has with people or companies he is talking to. You saw what happen with DECN.
BLACKCAT
deaf, Who was the one that introduce White Fox Ventures to invest in KUDZOO? I think a merger hear is possible in my opinion. Only Seth Shaw is the one who knows. If I were Seth Shaw I would not answer any question on any possible merger with anyone. These days SETH SHAW cannot trust anyone but himself.
TIC TOC TIC TOC WHAT TO DO
BLACKCAT
Deaf, we all know that Seth Shaw is looking to merge with a private company. KUDZOO is a private company. How would you know if this company is not one of the companies he is talking to or not. I heard he is talking to several companies. I have several family members that signed up on KUDZOO. This company is fantastic. Subscriptions are going through the roof.
Seth Shaw will have a winner and it will be soon.
This could be the one.
TIC TOC TIC TOC WHAT TO DO.
BLACKCAT
DEFINITION of 'OTCQB'
The venture stage marketplace for smaller or early-stage companies that report to a U.S. regulator such as the SEC or FDIC. The OTCQB is the middle tier of the three marketplaces for trading over-the-counter stocks provided and operated by the OTC Markets Group. The OTCQB has replaced the Financial Industry Regulatory Authority (FINRA)-operated OTC Bulletin Board (OTCBB) as the main market for trading OTC securities that report to a U.S. regulator. As it has no minimum financial standards, the OTCQB includes shell companies, penny stocks and small foreign issuers.
Tier 1 OTCQX
Tier 2 OTCQB
Tier 3 PINK SHEETS
Read more: OTCQB Definition | Investopedia http://www.investopedia.com/terms/o/otcqb.asp#ixzz4EJuYFHTQ
Follow us: Investopedia on Facebook
RAWMAN July 13, 2015, notice PARAGRAPH 4 in this release, it states all the details about all the options TAUG had.
Tauriga Sciences, Inc. Appoints Mr. Seth M. Shaw to Positions of Chairman and Chief Executive Officer and Ms. Ghalia Lahlou as Interim Chief Financial Officer Effective Immediately
Jul 13, 2015, 08:00 ET from Tauriga Sciences, Inc.
NEW YORK, Jul. 13, 2015 /PRNewswire/ --Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company, today announced the appointments of Mr. Seth M. Shaw as Chairman of the Board of Directors ("Chairman") and Chief Executive Officer ("CEO") and Ms. Ghalia Lahlou as Interim Chief Financial Officer ("Interim CFO"). Ms. Lahlou will maintain her current position as Corporate Secretary ("Secretary") as well. The outgoing CEO, Dr. Stella M. Sung will continue to support the Company in the important role of Chairman of the Medical Advisory Board.
After the above-mentioned appointments, Tauriga's Board of Directors will consist of three Board Members in total: Mr. Seth M. Shaw (Chairman), Dr. David L. Wolitzky (Independent), and Hingge Hsu, M.D., M.B.A. (Independent). However the Company the expects to appoint a fourth Board Member in the very near term.
Mr. Shaw had previously served as the CEO of the Company from August 22, 2012 through February 26, 2014 and has been working with the management team in numerous capacities ever since. As its Vice President Strategic Planning since February 2014, Mr. Shaw focused his efforts on financing operations and managing relationships with the Company's institutional investors. Ms. Lahlou had previously served as the Company's Secretary and focused her efforts on completing the Company's PCAOB audits and filings.
This morning the Company has announced its intention to fully divest its natural wellness business within the next two months. In addition, the Company is actively evaluating several potentially lucrative acquisition opportunities. The Company will be working tirelessly to both restore and create shareholder value and looks forward to updating shareholders with respect to progress as soon as practicable.
At this time the Company is exploring potential joint venture partnerships and other types of strategic alternatives to unlock value from its Pilus Energy LLC ("Pilus Energy") subsidiary. The Company believes that Pilus' main patent, United States Patent No. 8,354,267 for WasteWater-to-Value Technology, is potentially valuable in the marketplace. There will be a strong effort made, on behalf of this management team, to successfully monetize this patent.
The Company also wishes to express to shareholders that it currently does not have any plans to reverse split the stock. However it must also be disclosed that the Company faces the prospect of being delisted from the transparent OTCQB exchange should shares of Tauriga not close above $0.01 per share for a period of at least 10 consecutive trading days on or before the close of business October 12, 2015. There are two ways to remedy this share price deficiency, each of which would enable the Company to regain compliance with the OTCQB listing requirements. The first of these two remedies is simply better performance in Tauriga's share price which would be driven by fundamentals and execution of business initiatives. The second of these two available remedies would be a reverse split, which could result in the Company regaining compliance with listing requirements. Management is focused on building the fundamental value of the Company and is hopeful that any type of reverse split will not be necessary. However it is impossible to predict future share price, so management would consider a reverse split purely as a last resort, if it meant avoiding being delisted from the OTCQB. The Company views its continued listing on the OTCQB as extremely important, because a delisting would preclude institutional investors from continuing to support the Company.
Commenting on his appointment as Tauriga's CEO, Mr. Shaw stated, "The future success of Tauriga Sciences, Inc. is something that is enormously important to me both personally and professionally. I strongly believe that the Company has the potential to improve its fundamentals through hard work and execution. It is my hope that shareholder value can be both restored and created moving forward. There will be a herculean effort set forth to rebuild with a true team effort. The Company would also like to express its genuine appreciation to Dr. Stella M. Sung who worked through a number of difficult situations and made many important contributions. Lastly the Company is fortunate to have such a talented and dedicated individual as Ms. Ghalia Lahlou as its Interim CFO. "
Tauriga's outgoing CEO and newly appointed Chairman of Medical Advisory Board, Dr. Stella M. Sung commented, " I fully support the transition of the management team and look forward to continuing to work closely with the new management to create shareholder value. It has been a pleasure working with Mr. Shaw and Ms. Lahlou and I expect nothing but great accomplishments from them as well as the Board of Directors."
Interim CFO Ms. Ghalia Lahlou expressed, "I have a deep affection for this Company and I am pleased to expand my role with the Company moving forward. I will work closely with the Company's PCAOB auditors and to ensure accurate public filings. It also a great pleasure for me to work closely with Mr. Shaw, an individual who I deeply respect and enjoy an excellent professional relationship."
Personal Bio for Mr. Seth M. Shaw, Age 36
Seth M. Shaw, VP Strategic Planning
Mr. Shaw has extensive experience building companies and securing financing from a broad range of both domestic and international institutional investors. Over the past decade, he has been instrumental in securing more than $80 million in capital, in aggregate, for a number of small-cap and micro-cap companies.
Mr. Shaw started his career at American International Group (AIG) Global Investment Group, and furthered his growth capital experience working at a prestigious Manhattan based hedge fund (Harvest Capital Management). In 2005, he founded Novastar Resources Ltd, a natural resources exploration company focused on the exploration and acquisition of mineral properties containing the element thorium. During this period, Mr. Shaw secured more than $17 million in financing from top tier institutional investors and was an integral stakeholder in the completion of the merger between Novastar Resources and Thorium Power. During this period, he held the position of Director of Strategic Planning until mid-2007. Subsequently, the company changed its name to Lightbridge Inc. and currently trades on the NASDAQ (NASDAQ: LTBR).
Following the merger, Mr. Shaw has assisted several other companies in securing value added capital from institutional investors as well as providing management consulting. Among those, Mr. Shaw was instrumental in securing $12,000,000 from Tudor Investment Corp. for NASDAQ listed flat panel display developer Uni-Pixel Inc. (NASDAQ: UNXL). In addition, Mr. Shaw served as the founding CFO of Los Angeles based Biotech firm Physician Therapeutics LLC ("PTL") in 2004. Subsequently PTL merged with Targeted Medical Pharma ("TMP") (OTCQB: TRGM). Mr. Shaw had previously served as the CEO of Tauriga from August 22, 2012 through February 26, 2014. Throughout his tenure with Tauriga, Mr. Shaw has been instrumental in completing numerous private placement and most recently retired the entirety of the Company's convertible debt in October 2014. Mr. Shaw also continues to serve as Vice President Strategic Development for Breathe eCig Corp. (OTCQB: BVAP), a revenue generating electronic cigarette industry innovator and pioneer.
Mr. Shaw graduated from Cornell University in 2001 with a bachelor's degree in Policy Analysis Management and a concentration in Econometrics. An avid amateur astronomer and numismatist, Mr. Shaw currently serves on the Board of Directors of the Hudson Valley Community Center ("HVCC") of Dutchess County, New York, being awarded that organization's prestigious Young Leadership Award in October of 2014. In addition Mr. Shaw has been active in numerous charities and not for profits, including: The Robinhood Foundation (2007-2009), The Cypress Fund for World Peace and Security (2006-2010), and Save A Child's Heart ("SACH") (2011-Present), where he is a member of the New York City young leadership group. During 2015 Mr. Shaw has been actively supporting the charity "The 5 Under 40 Foundation" which provides multi faceted assistance and psychological support to young woman stricken by Breast Cancer.
Personal Bio for Ms. Ghalia Lahlou, Age 28
Ms. Lahlou joined Tauriga Sciences, Inc. in May 2011 as the Operations Manager based in the Montreal office. She previously worked in a number of operational roles ranging from the energy sector to healthcare. Ms. Lahlou was pivotal in interfacing and managing institutional and high net worth investors during her tenure with two early stage public companies. Prior to this, she served the role of assistant project manager at one of the largest steel manufacturing companies in North Africa. During her time there, she played a key role in the development of new product lines catering to the construction and building sector. At Tauriga Sciences, her role involves maintaining relationships with investors, managing daily operations and overseeing company communications with the investor community and the regulatory authorities in U.S and Canada. On July 9, 2015 Ms. Lahlou was appointed as Interim CFO and Director of Tauriga Sciences, Inc.
Ms. Lahlou graduated from McGill University, Montreal, Canada in [year] with a degree in Mechanical Engineering. Prior to that, she completed her studies in Health Sciences at Marianopolis College, Montreal.
About TAURIGA SCIENCES, INC.:
Tauriga Sciences, Inc. (OTCQB: TAUG) is a diversified life sciences company focused on generating profitable revenues through its present and future holdings. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. Please visit the Company's corporate website at www.tauriga.com
NON SOLICITATION:
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
Food and Drug Administration Disclaimer: None of the statements contained in this press release regarding any of the products either offered or to be offered in the future by the Company have been evaluated by the Food and Drug Administration. Additionally, none of the products is intended to diagnose, treat, cure, or prevent any disease.
CONTACT:
Mr. Seth M. Shaw
Chairman and Chief Executive Officer
Tauriga Sciences, Inc.
New York City: +1-917-796-9926
Montreal: +1-514-840-3697
Email: sshaw@tauriga.com
or
Ghalia Lahlou
Interim Chief Financial Officer
Tauriga Scienes, Inc.
Montreal: +1-514-840-3697
Email: glahlou@tauriga.com
http://www.tauriga.com
TIC TOC TIC TOC WHAT TO DO
BLACKCAT
Rawman, you need to get your facts correct. Do you not rember this news release Dated July 29,2015. I am posting it to refresh your memory. The company alway's had at it disposal the ability to reverse split the stock to be in compliance.Enjoy the reading.
Tauriga Sciences
July 29, 2015 16:49 ET
Tauriga Sciences Inc. Granted 7 Day Extension by OTC Markets to Maintain Listing on OTCQB Exchange
NEW YORK, NY--(Marketwired - Jul 29, 2015) - Tauriga Sciences, Inc. (OTCQB: TAUG) or ("Tauriga" or the "Company"), a diversified life sciences company, today announced that is has been granted a 7 calendar day extension by OTC Markets to continue trading on the OTCQB exchange despite the Company's inability to file its Form 10-K for the year ended March 31, 2015 ("Form 10-K") with the Securities and Exchange Commission ("SEC") prior to 5:30 pm EDT today, July 29, 2015. If this extension had not been granted, Tauriga's common stock would have been moved to the OTC Pink Limited Information category at open of trading Thursday, July 30, 2015.
Currently, Tauriga has until 5:30 pm EDT on Wednesday, August 5, 2015 to file its Form 10-K with the SEC, otherwise OTC Markets will proceed to move the Company shares to the OTC Pink Limited Information category as discussed above unless granted an additional extension by the OTC Markets. The Company is taking all possible steps to file its Form 10-K prior to the August 5, 2015 deadline.
About TAURIGA SCIENCES, INC.:
Tauriga Sciences, Inc. (OTCQB: TAUG) is a diversified life sciences company focused on generating profitable revenues through its present and future holdings. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. Please visit the Company's corporate website at www.tauriga.com
NON SOLICITATION:
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
Food and Drug Administration Disclaimer: None of the statements contained in this press release regarding any of the products either offered or to be offered in the future by the Company have been evaluated by the Food and Drug Administration. Additionally, none of the products is intended to diagnose, treat, cure, or prevent any disease.
Contact Information
CONTACT:
Mr. Seth M. Shaw
Chairman and Chief Executive Officer
Tauriga Sciences, Inc.
New York City: + 1-917-796-9926
Montreal: +1-514-840-3697
Email: sshaw@tauriga.com
TIC TOC TIC TOC WHAT TO DO
BLACKCAT
TAUG working hard to comply with OTCQB Requirements again after being DELISTED TO THE PINK SHEETS DUE TO COWAN NEGLIGENCE.
That is why they will win in the current lawsuits filed against
Cowan.
The OTCQB Venture Marketplace is for entrepreneurial and development stage U.S. and international companies that are unable to qualify for OTCQX. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. These standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors. Companies must meet a minimum $0.01 bid price test and may not be in bankruptcy.
Summary of Requirements for Companies
Current in their disclosure to a U.S. regulator or listed on a qualified international stock exchange
Meet a minimum bid price test of $0.01 and may not be in bankruptcy
Submit an application to OTCQB and pay an application and annual fee
Verify that the Company Profile displayed on www.otcmarkets.com is current and complete
Submit an OTCQB Annual Certification verifying officers, directors, controlling shareholders, and shares outstanding
Corporate Services for OTCQB Companies
OTC Disclosure & News Service enables companies to share reports, news, videos, investor presentations and more.
Real-Time Level 2 Quotes available for free to all investors on www.otcmarkets.com
TIC TOC TIC TOC WHAT TO DO
BLACKCAT
What Delisting Meant to TAUG on JULY 31,2015. From the OTCQB TO THE PINK SHEETS. (CORRECTION)NOT OTCBB CORRECT OTCQB
(OTCQB) - This is an electronic trading service offered by the Financial Industry Regulatory Authority (FINRA, formerly the NASD). Companies will trade here if they are current in their financial statements.
Pink Sheets - Considered even riskier than the OTCQB, the pink sheets are a quotation service. They do not require that companies register with the Securities and Exchange Commission (SEC) or remain current in their periodic filings. The stocks on the pink sheets are very speculative.
Delisting doesn't necessarily mean that a company is going to go bankrupt. Just as there are plenty of private companies that survive without the stock market or being listed. It is possible for a company to be delisted and still be profitable. However, delisting can make it more difficult for a company to raise money. For example, delisting may trigger a company's creditors to call in loans, or its credit rating might be further downgraded, increasing its interest expenses and potentially even pushing it into the red.
How Does It Affect You?
If a firm is unable to meet the listing requirements of the OTCQB upon which it is traded and resumes trading in the PINK SHEETS is quite obviously not in a great position. Each case of delisting needs to be looked at on an individual basis.
Even if a company continues to operate successfully after being delisted. People lose their faith in the stock. When a company's stock is demoted to the pink sheets, it loses its reputation.
Another problem for delisted stocks is that many institutional investors are restricted from researching and buying them. Investors who already own a stock prior to the delisting may be forced to sell their investment further depressing the company's share price by increasing the selling supply. This lack of coverage and buying pressure means the stock has an even steeper climb ahead to make it back on the OTCQB.
The Bottom Line
Some argue that delisting is too harsh because it punishes stocks that could still recover. However, allowing such companies to stay listed on the PINK SHEETS would result in the simply diluting the caliber of the companies that trade on them and degrading the respectability of the companies that maintain the listing requirements. Therefore, if a company that you own is delisted, it may not spell inevitable doom, but it is certainly a black mark on that company's reputation and, if your company can recover this would be a great a sign for your investments returns down the road.
THIS IS WHY TAUG WILL WIN A LARGE SETTLEMENT IN BOTH LAWSUITS.
TIC TOC TIC TOC WHAT TO DO
BLACKCAT
What Delisting Meant to TAUG on JULY 31,2015.
Over the Counter Bulletin Board (OTCBB) - This is an electronic trading service offered by the Financial Industry Regulatory Authority (FINRA, formerly the NASD). Companies will trade here if they are current in their financial statements.
Pink Sheets - Considered even riskier than the OTCBB, the pink sheets are a quotation service. They do not require that companies register with the Securities and Exchange Commission (SEC) or remain current in their periodic filings. The stocks on the pink sheets are very speculative.
Delisting doesn't necessarily mean that a company is going to go bankrupt. Just as there are plenty of private companies that survive without the stock market or being listed. It is possible for a company to be delisted and still be profitable. However, delisting can make it more difficult for a company to raise money. For example, delisting may trigger a company's creditors to call in loans, or its credit rating might be further downgraded, increasing its interest expenses and potentially even pushing it into the red.
How Does It Affect You?
If a firm is unable to meet the listing requirements of the OTCBB upon which it is traded and resumes trading in the PINK SHEETS is quite obviously not in a great position. Each case of delisting needs to be looked at on an individual basis.
Even if a company continues to operate successfully after being delisted. People lose their faith in the stock. When a company's stock is demoted to the pink sheets, it loses its reputation.
Another problem for delisted stocks is that many institutional investors are restricted from researching and buying them. Investors who already own a stock prior to the delisting may be forced to sell their investment further depressing the company's share price by increasing the selling supply. This lack of coverage and buying pressure means the stock has an even steeper climb ahead to make it back on the OTCBB.
The Bottom Line
Some argue that delisting is too harsh because it punishes stocks that could still recover. However, allowing such companies to stay listed on the PINK SHEETS would result in the simply diluting the caliber of the companies that trade on them and degrading the respectability of the companies that maintain the listing requirements. Therefore, if a company that you own is delisted, it may not spell inevitable doom, but it is certainly a black mark on that company's reputation and, if your company can recover this would be a great a sign for your investments returns down the road.
THIS IS WHY TAUG WILL WIN A LARGE SETTLEMENT IN BOTH LAWSUITS.
TIC TOC TIC TOC WHAT TO DO
BLACKCAT
NEWS OUT Tauriga Sciences, Inc.
July 07, 2016 07:00 ET
Tauriga Sciences Inc. Responds in Federal Court to the Multiple Motions Filed by Cowan Gunteski
NEW YORK, NY--(Marketwired - Jul 7, 2016) - Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), a life sciences technology Company, today announced that it has filed its Response with Untied States District Court Southern District Florida, Case No. 0:15-cv-62334, to answer the multiple motions filed by Cowan Gunteski & Co. P.A. ("Cowan Gunteski") on June 13, 2016. At this point, Cowan Gunteski has ten days to Respond to Tauriga's submission and at a date subsequent to that, the federal judge will make a ruling. Irrespective of this ruling, the Company will continue to prosecute this lawsuit against Cowan Gunteski and believes strongly in the evidentiary record and the merits of its legal arguments. The Company is currently seeking in excess of $3,000,000 USD in monetary damages and expects that number to continually increase up till the date of trial.
On June 29, 2016 the Company filed its Quarterly Report on Form 10-Q ("Quarterly Report") for the period ended June 30, 2015. The Company continues to work diligently towards its corporate goal of regaining its status as a fully reporting U.S. public Company. The Company became a delinquent filer and was delisted from the OTCQB Exchange on July 31, 2015 due to the malpractice committed by Cowan Gunteski during Fiscal Year 2014 as well as Cowan's subsequent conduct.
Lastly the Company wishes to reaffirm to shareholders its unwavering commitment to both restore and create lasting shareholder value. The Company's management and its Board of Directors are united in their commitment to build long term value for the shareholders. The Company continues to evaluate potentially intriguing acquisition opportunities and will notify shareholders, via a press release, should it enter into an agreement.
NON SOLICITATION:
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on Tauriga's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which Tauriga has little or no control. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by Tauriga with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
Contact Information
Contact:
Tauriga Sciences, Inc.
Mr. Seth Shaw
CEO
Tel: 1-917-796-9926
Email: sshaw@tauriga.com
Does anyone on this board think a DECN/TAUG
deal is still in play.
If so will TAUG benefit from such a deal?
TIC TOC TIC TOC WHAT TO DO
BLACKCAT
Who the hell is buying this POS. $.008-$.0087
Current price Bid $.008 Asked $.0087
It is possible Seth has a Ace up his sleeve.
TIC TOC TIC TOC WHAT TO DO
BLACKCAT7717
carlerasquin, Most on this board think TAUG is a POS why would the GREAT ONE Keith Berman still be interested in TAUG if TAUG has no value no sales, no law suit value, no income. Or is it possible TAUG has a hidden value that no one know about!!!!!!!!!!!
TIC TOC TOC TOC WHAT TO DO
BLACKCAT
pluto,TAUG will be current in days. Check out the filings
Blackcat
Cakes Up listing to OTCQB from pink sheets.No Reverse
Blackcat
Tauriga Sciences, Inc. Granted Extension Until July 6, 2016 to Respond to Motions Recently Filed by Cowan Gunteski & Co. P.A.
NEW YORK, NY–(Marketwired – Jun 30, 2016) – Tauriga Sciences, Inc. (OTC PINK: TAUG) (“Tauriga” or “the Company”), a life sciences technology company, today announced that Judge Robin L. Rosenberg granted Tauriga Sciences, Inc. an extension until July 6, 2016 to respond to the multiple motions filed by Cowan Gunteski & Co. P.A. on June 13, 2016 with regard to the Company’s currently pending action in the Federal District Court – Southern District Florida. The history of the action is more fully described in the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2015 filed with the Securities and Exchange Commission on June 29, 2016.
About TAURIGA SCIENCES, INC.:
Tauriga Sciences, Inc. (OTC PINK: TAUG) is a life sciences company focused on generating profitable revenues through its present and future holdings. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company’s business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. Please visit the Company’s corporate website at www.tauriga.com
NON SOLICITATION:
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
DISCLAIMER:
Forward Looking Statements
To the extent that statements contained in this press release are not descriptions of historical facts regarding Tauriga, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “may,” “will,” “expect,” “anticipate,” “estimate,” “intend,” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Examples of forward-looking statements contained in this press release include, among others, statements regarding our ability to prosecute successfully the litigation against Cowan Gunteski and the prospects of a potential acquisition. Tauriga undertakes no obligation to update or revise any forward-looking statements. The quoting and trading of the company’s common stock on the OTC Market Group’s OTC Link quotation system is often thin and characterized by wide fluctuations in trading prices, due to many factors that may have little to do with the company’s operations or business prospects. As a result, there may be volatility in the market price of the shares of the company’s common stock for reasons unrelated to operating performance. Moreover, the OTC Market Group’s OTC Link quotation system is not a stock exchange, and trading of securities on it is often more sporadic than trading of securities listed on the NASDAQ Stock market or another securities exchange.
Contact:
Tauriga Sciences, Inc.
Mr. Seth Shaw
CEO
Tel: 1-917-796-9926
Email: sshaw@tauriga.com
ZAL, Do not fall into a trap.Remember A leopard never changes its spots. Someone must be circling the wagons.
TIC TOC TIC TOC WHAT TO DO
BLACKCAT
ZAL, It will be more fun to meet you at the celebration party when TAUG goes to new highs.
TIC TOC TIC TOC WHAT TO DO $$$$$$$$$$$$$$$
BLACKCAT
TAUG has review several possible deals. The company is waiting for the GREEN LIGHT on fully reporting before making a final decision.
TIC TOC TIC TOC WHAT TO DO
BLACKCAT
That can only mean Seth Shaw has a better deal with someone else.
TIC TOC TIC TOC WHAT TO DO.
BLACKCAT
TAUG is waiting for the answer from the Lawyers.Where the trial takes place does not matter if you have a good case.
TIC TOC TIC TOC WHAT TO DO.
BLACKCAT